Shan Lu
- Pharmaceutical Science top 2%
- Drug Solubulity and Delivery Systems 9
- Advanced Drug Delivery Systems 3
- Pharmacology top 5%
- Pharmacological Effects of Natural Compounds 8
- Inflammatory mediators and NSAID effects 3
- Aging top 10%
- Nephrology top 5%
- Acute Kidney Injury Research 4
- Cancer Research top 10%
-
- Crystallization and Solubility Studies 6
-
- Phytochemicals and Antioxidant Activities 3
-
- Essential Oils and Antimicrobial Activity 3
- Journals
- Journal of Pharmaceutical Sciences (2 papers)Journal of Biomedical Nanotechnology (2 papers)Biomedicine & Pharmacotherapy (2 papers)
- Partner nations
- ChinaUnited StatesFrance
In The Last Decade
Shan Lu
52 papers receiving 1.4k citations
Peers
Comparison fields: 5 of 118
- Pharmaceutical Science 183
- Pharmacology 150
- Aging 26
- Nephrology 102
- Cancer Research 189
Countries citing papers authored by Shan Lu
This map shows the geographic impact of Shan Lu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shan Lu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shan Lu more than expected).
Fields of papers citing papers by Shan Lu
This network shows the impact of papers produced by Shan Lu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shan Lu. The network helps show where Shan Lu may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Shan Lu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 1 | |
| 2 | 2024 | 9 | |
| 3 | 2024 | 4 | |
| 4 | 2023 | 75 | |
| 5 | 2023 | 6 | |
| 6 | 2022 | 27 | |
| 7 | 2022 | 22 | |
| 8 | 2021 | 65 | |
| 9 | 2021 | 42 | |
| 10 | 2021 | 58 | |
| 11 | 2020 | 47 | |
| 12 | 2020 | 29 | |
| 13 | 2020 | 8 | |
| 14 | 2019 | 3 | |
| 15 | 2019 | 20 | |
| 16 | Ferulic acid attenuates liver fibrosis and hepatic stellate cell activation via inhibition of TGF-β/Smad signaling pathway | 2018 | 2 |
| 17 | 2018 | 36 | |
| 18 | 2018 | 40 | |
| 19 | 2018 | 12 | |
| 20 | 2016 | 15 |
About Shan Lu
Shan Lu is a scholar working on Pharmaceutical Science, Aging, Pharmacology, Nephrology and Biochemistry, having authored 53 papers that have together received 1.4k indexed citations. Recurring topics across this work include Drug Solubulity and Delivery Systems (9 papers), Pharmacological Effects of Natural Compounds (8 papers), Crystallization and Solubility Studies (6 papers), Acute Kidney Injury Research (4 papers), Phytochemicals and Antioxidant Activities (3 papers), Advanced Drug Delivery Systems (3 papers), Essential Oils and Antimicrobial Activity (3 papers) and Inflammatory mediators and NSAID effects (3 papers). The work is most often cited by research in Pharmaceutical Science (183 citations), Pharmacology (150 citations), Aging (26 citations), Nephrology (102 citations) and Cancer Research (189 citations). Shan Lu has collaborated with scholars based in China, United States and France. Frequent co-authors include Xiaodi Fan, Kai Li, Zhenzhen Li, Hongzhi Du, Guoqing Zhao, Yunyun Wang, Yan Cao, Zhenbo Su, Xuyang Li and Meng Lu. Their work appears in journals such as Journal of Pharmaceutical Sciences, Journal of Biomedical Nanotechnology, Biomedicine & Pharmacotherapy, Journal of Controlled Release and Food Chemistry.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.